加载中...
共找到 16,806 条相关资讯
The financial world is anxiously awaiting the planned IPO of SpaceX, the reigning king of private companies. Analysts suggest the company is targeting a record-shattering valuation of approximately $1.75 trillion, with plans to raise between $45 billion and $75 billion.
The number of job openings in the U.S. and the speed at which businesses hire to fill them are still depressed — a depressing thought for anyone looking for work.
The Institute for Supply Management's purchasing managers index for services providers was 53.6, suggesting continued expansion, though price pressures from the war in Iran weighed on growth.
Hiring picked up in March, but the rate of job openings ticked down to 4.1%, emphasizing a continued stretch of relatively low dynamism in the market.
CNBC's Diana Olick reports Span, Nvidia and PulteGroup are testing home based data center nodes, using unused grid capacity to cut costs, ease community pushback and support growing AI demand.
US job openings were little changed in March, with available positions falling slightly to 6.87 million from a revised 6.92 million in February. Mike McKee reports on "Bloomberg Open Interest.
Sales of new single-family homes rose to 682,000 in March, from 635,000 in February. A consensus of economists polled by The Wall Street Journal expected 660,000 sales in March.
U.S. job openings slipped in March, but a surge in hiring suggested the labor market was regaining its footing after struggling last year.
A deal, which isn't finalized, would go through Murdoch's Lupa Systems investment firm.
The largest part of the economy took a hit in April from the fallout from the Iran war, a survey showed, but businesses still grew at a fairly robust pace even as they grew more cautious.
The value of imports rose by 2.3% while exports increased 2% in March from the prior month. The trade gap now stands at $60.3 billion.
Wall Street's top regulator is crafting regulations to undo a dormant Biden-era rule intended to help investors gauge companies' climate-related spending and risks, according to a notice on the U.S. budget office website.
History leans toward resilience for equities after rate surges. Forward 1- and 2-year returns skew positive across many yield spike scenarios.
Wall Street's main indexes recovered on Tuesday, as easing oil prices provided relief to equity markets despite renewed tensions in the Middle East that continue to cloud the global outlook. Dow Jones Industrial Average rose 198 points, or 0.41%, while the S&P 500 gained 0.63% and the Nasdaq Composite climbed 0.87%.
Global central banks are grappling with the oil price shock caused by the war in the Middle East. Investors now anticipate rate-setters to increase borrowing costs in a bid to combat runaway inflation.
Despite escalating Middle East tensions and rising oil prices, equity markets remain resilient, with investors focused on Q1 earnings and upward revisions. Elevated oil prices are expected to persist through year-end, increasing input costs and threatening consumer spending and GDP growth in coming months.
Both exports and imports rose after the Supreme Court struck down many of the president's highest levies in February.
Stocks pulled back from all-time highs Monday but are rebounding in Tuesday's premarket session as investors weigh escalating tensions between the U.S. and Iran. Kevin Green breaks down what a potential ceasefire breakdown could mean for energy markets—and how the current setup compares to the oil price spike seen in 2022 after the Russian attack on Ukraine.
Stock futures are higher this morning as the market rebounds from losses yesterday caused by uncertainty over developments in the Middle East; shares of Palantir are slipping despite a strong earnings report from the software maker; chipmaker AMD is due to release its quarterly numbers after the closing bell; Pinterest shares are rallying after the social media company's results and outlook topped Wall Street expectations; and reports on the labor market and home sales will kick off a busy week of economic data. Here's what you need to know.
AI is poised to transform biopharma by reducing drug development time, cost, and risk, recalibrating the industry's core valuation drivers. AI-enabled assets show a dramatic improvement in risk-adjusted net present value, with my modeled example shifting from negative $238.5M to positive $356.5M.